Magnetom Vida
Payments companies reported to CMS as associated with Magnetom Vida. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Magnetom Vida, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Magnetom Vida
These are the largest totals companies reported as associated with Magnetom Vida. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Ohliger | Boston, MA | Internal Medicine | $11,916.11 |
| Javier Villanueva-Meyer | San Francisco, CA | Diagnostic Radiology | $11,867.65 |
| Kimberly Kallianos | San Francisco, CA | Diagnostic Radiology | $11,814.25 |
| George Koberlein | Cincinnati, OH | Pediatric Radiology | $10,899.45 |
| Christopher Hess | San Francisco, CA | Diagnostic Radiology | $10,833.40 |
| Thomas Goodman | New Haven, CT | Diagnostic Radiology | $9,389.40 |
| Steffen Huber | New Haven, CT | Diagnostic Radiology | $9,389.40 |
| Amit Mahajan | Trumbull, CT | Internal Medicine | $9,389.30 |
| David Saul | Deptford, NJ | Pediatric Radiology | $9,169.03 |
| Vipul Sheth | Stanford, CA | Diagnostic Radiology | $8,371.67 |
Prescribed Magnetom Vida?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.